Perrigo Gets Technical Rating Upgrade | Stock News & Stock Market … – Investor's Business Daily

This post was originally published on this site

In a welcome move, Perrigo (PRGO) saw its Relative Strength Rating rise from 67 to 72 on Tuesday.

XAutoplay: On | Off IBD’s unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock’s price movement over the last 52 weeks compares to all the other stocks in our database.

Decades of market research shows that the top-performing stocks often have an 80 or higher RS Rating as they launch their largest price moves. See if Perrigo can continue to rebound and hit that benchmark.


Looking For Winning Stocks? Try This Simple Routine


Perrigo is building a flat base with an 89.97 buy point. See if the stock can clear the breakout price in heavy trading.

Although earnings and sales growth came in at -5% and -8%, respectively, in the latest report, that shows two quarters of improvement for earnings and one for revenue. The company is expected to release its next quarterly numbers on or around Nov. 10.

Perrigo earns the No. 7 rank among its peers in the Medical-Generic Drugs industry group. ANI Pharmaceuticals (ANIP), Neos Therapeutics (NEOS) and Akorn (AKRX) are among the top 5 highly rated stocks within the group.

RELATED:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

This post was originally published on *this site*